News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML
Talha Badar/X
Mar 4, 2025, 10:55

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared an article by Jing Lu, et al. on X:

“Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Venetoclax plus decitabine NOT INFERIOR to intensive chemo in young fit AML.

VEN+DEC was well tolerated.”

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Authors: Jing Lu, et al.

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

 

AML cancer chemotherapy decitabine fight against cancer Global fight against cancer Jing Lu Mayo Clinic OncoDaily Oncology Talha Badar venetoclax
Special Coverage
Opinion
May 1, 2025, 17:39
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey
Insight
May 1, 2025, 17:30
Gustavo Viani: Supercharged Spinal Metastases SBRT-SIB Boost Scores High Local Control 
Blog
May 1, 2025, 17:29
Muhammad Shaalan Beg shared methods to reimagine patient-centric clinical trials at AACR25 - Moffitt Cancer Center
Blog
May 1, 2025, 17:15
Shaban Juma Shares Vital Insights on Lung Cancer and Its Primary Risk Factors - Cancer Fight Tanzania
Drugs
May 1, 2025, 17:14
Ana Velázquez Mañana highlights NEJM study by John Heymach on Zongertinib’s efficacy in HER2-Mutant NSCLC at AACR25
Blog
May 1, 2025, 17:09
Aynur Aktas: Our Abstract Has Been Selected for Oral Presentation at MASCC 2025
Insight
May 1, 2025, 17:01
Ken Cardona leads EA7211/STRASS 2 clinical trial: A randomized study in retroperitoneal sarcoma - ECOG-ACRIN Cancer Research Group
Blog
May 1, 2025, 16:54
Phnom Penh Launches Cancer Care Projects to Strengthen Services - City Cancer Challenge
Blog
May 1, 2025, 16:49
SHRO honors three medical students from the University of Siena for completing U.S. research program
Blog
May 1, 2025, 16:46
MedAccess and Elekta Partner to Launch Pay-Per-Use Radiotherapy Model for Cancer Care in LMICs
Blog
May 1, 2025, 16:38
Wade Swenson: Registration is now open for the 2025 Rural Oncology Conference
Insight
May 1, 2025, 16:36
Drew Moghanaki: CW pain is rare, and when it occurs always heals